GC Cell Corporation (KOSDAQ:144510)
20,150
+380 (1.92%)
May 21, 2026, 12:20 PM KST
GC Cell Market Cap
GC Cell has a market cap or net worth of 297.09 billion as of May 20, 2026. Its market cap has decreased by -7.83% in one year.
Market Cap
297.09B
Enterprise Value
379.84B
Revenue
165.52B
Ranking
n/a
PE Ratio
n/a
Stock Price
20,150.00
Market Cap Chart
Since June 23, 2016, GC Cell's market cap has decreased from 507.65B to 297.09B, a decrease of -41.48%. That is a compound annual growth rate of -5.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 297.09B | -20.44% |
| Dec 30, 2025 | 373.42B | 4.85% |
| Dec 30, 2024 | 356.14B | -47.90% |
| Dec 28, 2023 | 683.53B | -3.46% |
| Dec 29, 2022 | 708.04B | -55.94% |
| Dec 30, 2021 | 1.61T | 65.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Proteina | 484.62B |
| SillaJen | 417.05B |
| Genomictree | 343.24B |
| Helixmith | 333.38B |
| Anterogen.Co.,Ltd. | 316.69B |
| BINEX | 301.60B |
| HLB Therapeutics | 278.15B |
| NeoImmuneTech | 247.66B |